NCRI Press Release, 9 November 2016
Marker for aggressive prostate cancer doubles-up as a drug target
Download the attachmentRecent Tweets
-
RT @TCCResearchTeam : Don't forget to submit your abstract before Sunday 2nd September for the chance to showcase your research @NCRI_partne …
19 hours ago -
Submit your #cancerresearch findings before Sunday 2nd September for the chance to showcase your new data to the in… https://t.co/TrTAEIqEWt
20 hours ago -
Are you a self-motivated and sharp minded individual with experience of working in a busy office environment? We're… https://t.co/w3fP38Qt7U
1 day ago
What's Happening
- 20 Aug 2018We're recruiting for a Clinical Studies Group Coordinator. Deadline for applications is 2/9
- 13 Aug 2018Register now for the 5th Annual Children's Cancer & Leukaemia Trials Meeting: 26 November 2018
- 1 Aug 2018Registration and call for proposals now open - NCRI Supportive & Palliative Care CSG 2018 Trials Meeting
- 25 Jul 2018Redesigning clinical research to improve outcomes for older people
- 19 Jul 2018NCRI recruiting for Sponsorship and Exhibition Manager
- 18 May 2018NCRI Consumer Membership Applications to the CSGs - Closing Soon!
- 3 May 2018Dr Iain Frame appointed NCRI CEO
RSS Feed